Richard Ho
Faculty Member
Last active: 11/10/2016

  1. Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance. Lee HH, Leake BF, Kim RB, Ho RH (2017) Mol Pharmacol 91(1): 14-24
    › Primary publication · 27777271 (PubMed) · PMC5198512 (PubMed Central)
  2. The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive acute myelogenous leukemia. Schechter T, Gassas A, Chen H, Pollard J, Meshinchi S, Zaidman I, Hitzler J, Abdelhaleem M, Ho R, Domm J, Woolfrey A, Frangoul H (2015) Biol Blood Marrow Transplant 21(1): 172-5
    › Primary publication · 25139215 (PubMed)
  3. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Lavoie Smith EM, Li L, Chiang C, Thomas K, Hutchinson RJ, Wells EM, Ho RH, Skiles J, Chakraborty A, Bridges CM, Renbarger J (2015) J Peripher Nerv Syst 20(1): 37-46
    › Primary publication · 25977177 (PubMed) · PMC4610712 (PubMed Central)
  4. Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP). Bussel JB, Hsieh L, Buchanan GR, Stine K, Kalpatthi R, Gnarra DJ, Ho RH, Nie K, Eisen M (2015) Pediatr Blood Cancer 62(2): 208-213
    › Primary publication · 25345874 (PubMed) · PMC4309514 (PubMed Central)
  5. Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin Therapy. Van Driest SL, McGregor TL, Velez Edwards DR, Saville BR, Kitchner TE, Hebbring SJ, Brilliant M, Jouni H, Kullo IJ, Creech CB, Kannankeril PJ, Vear SI, Brothers KB, Bowton EA, Shaffer CM, Patel N, Delaney JT, Bradford Y, Wilson S, Olson LM, Crawford DC, Potts AL, Ho RH, Roden DM, Denny JC (2015) PLoS One 10(6): e0127791
    › Primary publication · 26030142 (PubMed) · PMC4452656 (PubMed Central)
  6. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance. Lee HH, Leake BF, Teft W, Tirona RG, Kim RB, Ho RH (2015) Mol Cancer Ther 14(4): 994-1003
    › Primary publication · 25695959 (PubMed) · PMC4394048 (PubMed Central)
  7. The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population. Vear SI, Ayers GD, Van Driest SL, Sidonio RF, Stein CM, Ho RH (2014) Br J Haematol 165(6): 832-5
    › Primary publication · 24601977 (PubMed) · PMC4043918 (PubMed Central)
  8. Targeted Busulfan therapy with a steady-state concentration of 600-700‚ÄČng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Maheshwari S, Kassim A, Yeh RF, Domm J, Calder C, Evans M, Manes B, Bruce K, Brown V, Ho R, Frangoul H, Yang E (2014) Bone Marrow Transplant 49(3): 366-9
    › Primary publication · 24317124 (PubMed)
  9. Warfarin pharmacogenomics in children. Vear SI, Stein CM, Ho RH (2013) Pediatr Blood Cancer 60(9): 1402-7
    › Primary publication · 23682017 (PubMed) · PMC3786327 (PubMed Central)
  10. t(17;19) in Children with Acute Lymphocytic Leukemia: A Report of 3 Cases and a Review of the Literature. Minson KA, Prasad P, Vear S, Borinstein S, Ho R, Domm J, Frangoul H (2013) Case Rep Hematol : 563291
    › Primary publication · 23346431 (PubMed) · PMC3549381 (PubMed Central)